Breast cancer can be categorized into three primary subtypes based on the expression levels of estrogen receptor (ER), progesterone receptor (PR), and human epidermal growth factor receptor 2 (HER2): hormone receptor-positive, HER2-positive, and triple-negative breast cancer (TNBC) (2). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.